Literature DB >> 25447562

The expression of syntaphilin is down-regulated in the optic nerve after axonal injury.

Akiko Miki1, Akiyasu Kanamori2, Makoto Nakamura1, Yoshiko Matsumoto1, Junji Mizokami1, Akira Negi1.   

Abstract

The impairment of mitochondrial function is an important pathogenic factor in glaucoma and other optic neuropathies in which retinal ganglion cell (RGC) death is the fundamental pathology. Syntaphilin was recently discovered as a docking protein that affects mitochondrial mobility. However, no reports have investigated the involvement of syntaphilin in the visual system. We investigated the expression of syntaphilin in the rat retina, optic nerve and brain. The expression of syntaphilin exhibited varying patterns in the visual system. Syntaphilin was expressed in retinal ganglion cells in the retina, in the cell bodies of neurons in the superior colliculus and was abundant in the astrocytes of rat optic nerves (similar to the findings that syntaphilin is expressed in human optic nerves). After optic nerve transection, which caused RGC death and axonal degeneration, quantitative real-time RT-PCR was used to assess changes in gene expression in the rat retina and optic nerve. Syntaphilin gene and protein expression in the optic nerve was downregulated 3 and 7 days after optic nerve transection. Our study suggests that syntaphilin expression in astrocytes at the optic nerve might be involved in axonal injury.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Axonal injury; Axonal transport; Optic nerve; Syntaphilin; Visual pathway

Mesh:

Substances:

Year:  2014        PMID: 25447562     DOI: 10.1016/j.exer.2014.10.017

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  1 in total

1.  Local Accumulation of Axonal Mitochondria in the Optic Nerve Glial Lamina Precedes Myelination.

Authors:  Samantha J Wilkison; Cora L Bright; Ricardo Vancini; Daniel J Song; Howard M Bomze; Romain Cartoni
Journal:  Front Neuroanat       Date:  2021-05-20       Impact factor: 3.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.